Administration of ARS-1 or Albuterol in Subjects With Persistent Asthma
Trial details
- Registry ID
- NCT05363670
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Administration of ARS-1 or Albuterol in Subjects With Persistent AsthmaNCT05363670 | SPRY | Phase 2 | Completed | 2024-02-02Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |